ANESTHETIC MANAGEMENT AND INTENSIVE CARE DURING PERIOPERATIVE PERIOD OF ABDOMINAL DELIVERY IN PREGNANT WOMEN WITH PULMONARY ARTERIAL HYPERTENSION.
A E BautinA V YakubovYu A KokoninaA B Il'inO A LiO B IrtyugaV A MazurokI E ZazerskavaO M MoiseevaPublished in: Anesteziologiia i reanimatologiia (2018)
The median age was 27 (23; 29) years. Among the patients, there were 4 (19%) cases of idiopathic PAH and in 17 (81%) women PAH was associated with congenital heart disease (CHD); 12 (57%) patients'demonstrated Eisenmenger syndrome. Baseline SPAP was 90 (82; 103) mm Hg. SpO2 90 (85,95)%. All women taken PAH-specific therapy (sildenafil) before delivery. Caesarean section (CS) were performed at 32 (28; 34) weeks. In 20 cases CS was perfofined under epidural anesthesia and in one case under general anesthesia due thrombocytopenia. Inhaled nitric oxide (NO) was administered intraoperative to all women in a dose of 40-60 ppm. Postoperative period was uncomplicated in five women (23?8%). Decompensation with PAP rise, acute right ventricular failure and hypoxemia developed in 16 (76,2%) cases 30 (24, 40) h after abdominal delivery. These patients required combined PAH-specific therapy (NO, sldenafil, iloprost) and inotropic agents, additionallyrespiratory support was used in four patients. The median ICU stay was 13 (9; 22) days. 3 patients died (14?2%); mortality in Eisenmenger syndrome cases was 25% (3/12). 18 healthy babies.
Keyphrases
- end stage renal disease
- ejection fraction
- pregnant women
- newly diagnosed
- nitric oxide
- pulmonary arterial hypertension
- prognostic factors
- patients undergoing
- intensive care unit
- polycystic ovary syndrome
- stem cells
- cardiovascular disease
- patient reported outcomes
- metabolic syndrome
- insulin resistance
- coronary artery disease
- cardiac surgery
- type diabetes
- extracorporeal membrane oxygenation
- spinal cord
- risk factors
- hepatitis b virus
- adipose tissue